No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Hatch Medical Enters Into An Exclusive Brokerage Relationship with Fixit Medical to Broker Novel Percutaneous Drainage Catheter Fixation Device Cingo

Editor: What To Know

  • There is an aperture within the base that accepts the drainage catheter and with the lid in place the device provides complete protection to the catheter, including a water-tight seal ideal for showering.
  • We look forward to working with Hatch to identify a commercial partner committed to bringing the Cingo™ drainage catheter fixation device to market, so that patients and healthcare institutions can enjoy the benefits this game changing technology brings when compared to current fixation methods.
  • Image-guided percutaneous drainage has become the therapeutic treatment of choice for a wide variety of abnormal fluid collections such as abscesses and ascites, and is also widely used for the relief of renal and biliary obstruction.

February 2, 2021

Hatch Medical, L.L.C. notes the exclusive brokerage relationship is with inventor and CEO, Dr. Robert Ward, MB BS FRCS FRCR, and his company, Fixit Medical, Ltd. Hatch Medical will seek to sell or out-license Dr. Ward’s next generation drainage catheter fixation device, Cingo.

Dr. Ward, a specialist in vascular and interventional radiology, has developed the most advanced and patient-centric drainage catheter fixation device available today. We are delighted to be partnering with Fixit Medical to bring their exciting technology to the market,” said Paul Gianneschi, Managing Principal of Hatch Medical.

Image-guided percutaneous drainage has become the therapeutic treatment of choice for a wide variety of abnormal fluid collections such as abscesses and ascites, and is also widely used for the relief of renal and biliary obstruction. These procedures have resulted in reduced morbidity and mortality and have helped to reduce length of hospital stays and costs. A drainage catheter is generally inserted to accomplish this clinical outcome by an interventional radiologist, a physician who specializes in image-guided procedures.   The global interventional radiology drainage procedures market was valued at US$ 0.59 Bn in 2019 and is projected to expand at a CAGR of ~6% from 2020 to 2030.

Fixit Medical’s Cingo™ is the future of catheter fixation, featuring industry leading catheter fixation, durability and functionality. The device is produced out of a soft thermoplastic elastomer in two parts; a highly flexible base able to conform to curved anatomy with an integral housing and lid. There is an aperture within the base that accepts the drainage catheter and with the lid in place the device provides complete protection to the catheter, including a water-tight seal ideal for showering.

Cingo™ features best in class catheter fixation through a pull-force dissipating design and an estimated two-week wear time. Cingo™ also boasts a revolutionary design that protects catheters from twisting and kinking, provides easy access to the catheter exit site for improved visibility and cleaning, and includes an ingenious integral shower-safe feature.

The Cingo™ drainage catheter fixation technology is available for license, sale or partnering to interested third parties through an exclusive agreement with Hatch Medical.

Dr. Ward commented, “Hatch Medical is an ideal partner given their vast experience in the interventional radiology medical device market. We look forward to working with Hatch to identify a commercial partner committed to bringing the Cingo™ drainage catheter fixation device to market, so that patients and healthcare institutions can enjoy the benefits this game changing technology brings when compared to current fixation methods.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy